In 2024, more than 379 thousand Almaty residents received medicines in clinics at the expense of the guaranteed volume of free medical care and compulsory medical insurance. The Health Insurance Fund spent almost 46 billion tenge on this. The Almaty branch of the Health Insurance Fund told forbes.kz about the most expensive medicines that our citizens receive.
"Spinraza", 34 million tenge
This is the world's first drug for the treatment of spinal muscular atrophy. "Spinraza" stops the progression of the disease, the death of neurons in the spinal cord stops.
Translarna, 12 million tenge
Translarna therapy effectively slows the progression of Duchenne muscular dystrophy and helps patients stay active longer.
"Gemlibra", 3.3 million tenge
Hemlibra helps people with hemophilia A, a condition in which blood does not clot properly. The drug prevents dangerous bleeding and improves quality of life, allowing patients to lead more active lives.
"Tagrisso", 3.1 million tenge
"Tagrisso" is prescribed to patients with lung cancer, which helps slow down the growth of the tumor and prolongs the life of patients. It is an effective treatment, especially for those who have not helped with other drugs.
“Imbruvika”, 2.5 million tenge
Imbruvica is an innovative drug used to treat various forms of cancer, including chronic lymphocytic leukemia and diseases affecting the blood-forming organs. Imbruvica helps cancer patients continue their treatment and fight the disease more effectively.
"Ponatinix", 2.5 million tenge
Ponatinix helps with chronic myeloid leukemia, a type of blood cancer. The drug blocks harmful molecules that contribute to cancer development and helps stop the disease from progressing.
“Kotellik”, 2.1 million tenge
Kotellic is a drug used to treat stomach cancer and other tumors. It works by blocking receptors on the surface of cancer cells that activate their growth. The drug significantly improves the prognosis for patients suffering from aggressive forms of cancer and offers a chance for successful treatment, especially when combined with other therapies.
“Tafinlar”, 1.7 million tenge
Tafinlar is used to treat skin cancer (melanoma) and other tumors associated with a mutation in the BRAF gene. It blocks the growth and spread of cancer cells, which helps melanoma patients achieve stable treatment results and prolong their lives. It is one of the most advanced drugs for the treatment of skin cancer, which has proven its effectiveness in clinical trials.
"Stelara", 1.2 million tenge
Stelara is the first biological drug for the treatment of moderate to severe Crohn's disease in adults. In 2024, 205 patients received it under the compulsory medical insurance.
"Elpag", 590 thousand tenge
Doctors prescribe Elpag to patients to increase the number of platelets. It is used to treat immune thrombocytopenia. The drug helps prevent dangerous diseases such as strokes or heart attacks by improving the condition of the cardiovascular system.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
"Spinraza", 34 million tenge
This is the world's first drug for the treatment of spinal muscular atrophy. "Spinraza" stops the progression of the disease, the death of neurons in the spinal cord stops.
Translarna, 12 million tenge
Translarna therapy effectively slows the progression of Duchenne muscular dystrophy and helps patients stay active longer.
"Gemlibra", 3.3 million tenge
Hemlibra helps people with hemophilia A, a condition in which blood does not clot properly. The drug prevents dangerous bleeding and improves quality of life, allowing patients to lead more active lives.
"Tagrisso", 3.1 million tenge
"Tagrisso" is prescribed to patients with lung cancer, which helps slow down the growth of the tumor and prolongs the life of patients. It is an effective treatment, especially for those who have not helped with other drugs.
“Imbruvika”, 2.5 million tenge
Imbruvica is an innovative drug used to treat various forms of cancer, including chronic lymphocytic leukemia and diseases affecting the blood-forming organs. Imbruvica helps cancer patients continue their treatment and fight the disease more effectively.
"Ponatinix", 2.5 million tenge
Ponatinix helps with chronic myeloid leukemia, a type of blood cancer. The drug blocks harmful molecules that contribute to cancer development and helps stop the disease from progressing.
“Kotellik”, 2.1 million tenge
Kotellic is a drug used to treat stomach cancer and other tumors. It works by blocking receptors on the surface of cancer cells that activate their growth. The drug significantly improves the prognosis for patients suffering from aggressive forms of cancer and offers a chance for successful treatment, especially when combined with other therapies.
“Tafinlar”, 1.7 million tenge
Tafinlar is used to treat skin cancer (melanoma) and other tumors associated with a mutation in the BRAF gene. It blocks the growth and spread of cancer cells, which helps melanoma patients achieve stable treatment results and prolong their lives. It is one of the most advanced drugs for the treatment of skin cancer, which has proven its effectiveness in clinical trials.
"Stelara", 1.2 million tenge
Stelara is the first biological drug for the treatment of moderate to severe Crohn's disease in adults. In 2024, 205 patients received it under the compulsory medical insurance.
"Elpag", 590 thousand tenge
Doctors prescribe Elpag to patients to increase the number of platelets. It is used to treat immune thrombocytopenia. The drug helps prevent dangerous diseases such as strokes or heart attacks by improving the condition of the cardiovascular system.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
